Patient
SITE004-0144
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE004 (DEU) (Dr. Tanaka)
consented 2026-02-20
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-18 (study day 114); relationship: RELATED
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-11-09 (study day 75); relationship: not assessed
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-04 (study day 70); relationship: NOT RELATED
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-10-21 (study day 56); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.